[40] This deserves further study. Furthermore, frequency of electrocardiogram abnormalities during treatment with DPP-4 inhibitors has not been higher than in the placebo-administered groups.

The enzyme dipeptidyl peptidase-4 (DPP-4 ... the strategy to inhibit the enzyme has been explored. Several DPP-4 inhibitors are in clinical development; these are orally active and increase ...

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

In a recent study published in BMJ, researchers from the Seoul National University, South Korea, observed type 2 diabetes patients between the ages of 40 and 69 years being treated with dipeptidyl ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with a lower risk for incidental Parkinson disease among older adults with type 2 diabetes.

Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.

The results, published in JAMA Network Open, examined other popular types of diabetes meds including insulin, metformin, dipeptidyl-peptidase-4 inhibitors (DPP-4is), sodium-glucose cotransporter-2 ...

Serious side effects of metformin are rare. Less serious side effects, like digestive issues and headaches, are common, but these usually go away with time. You can reduce the chances of side ...

4 However, much to the disappointment of many healthcare professionals engaged in designing exercise programs for patients with type 2 diabetes mellitus, the DARE trial only showed limited changes ...